Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Predicting Reaction Outcomes02:24

Predicting Reaction Outcomes

9.1K
Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
9.1K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

154
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
154
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

152
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
152
Protein Networks02:26

Protein Networks

4.2K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.2K
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

124
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
124
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

165
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
165

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Italian Cystic Fibrosis Registry (ICFR). Report 2023-2024].

Epidemiologia e prevenzione·2026
Same author

From tissue to outcome - how perioperative vaginal estrogen transforms prolapse surgery results: a systematic review and meta-analysis of clinical evidence and outcomes.

Climacteric : the journal of the International Menopause Society·2026
Same author

Prospective and external evaluation of an AI model for continuous and early prediction of moderate and severe AKI in critically ill patients.

Intensive care medicine experimental·2026
Same author

Laparoscopic and robotic ventral rectopexy for posterior compartment disorders: a multicentric study in a gynecological setting.

Techniques in coloproctology·2026
Same author

Diagnostic accuracy of radiolabelled-WBC scintigraphy in patients with antibiotic therapy.

European journal of nuclear medicine and molecular imaging·2026
Same author

TECAR Therapy in Pelvic Floor Rehabilitation for Women with Pelvic Pain: A Case-Control Study.

International urogynecology journal·2026

Related Experiment Video

Updated: Nov 7, 2025

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.9K

A dynamic Bayesian network model for predicting organ failure associations without predefining outcomes.

Roberto Alberto De Blasi1, Giuseppe Campagna1, Stefano Finazzi2

  • 1Dipartimento di Scienze Medico-Chirurgiche e Medicina Traslazionale, Università degli studi di Roma Sapienza, Ospedale Sant'Adrea, Rome, Italy.

Plos One
|April 28, 2021
PubMed
Summary
This summary is machine-generated.

This study introduces a dynamic Bayesian network (BN) model to predict organ failure interrelationships in critically ill patients. The model identifies evolving organ associations over time, offering new insights beyond mortality metrics.

More Related Videos

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.1K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.4K

Related Experiment Videos

Last Updated: Nov 7, 2025

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.9K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.1K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.4K

Area of Science:

  • Critical care medicine
  • Computational biology
  • Medical informatics

Background:

  • Bayesian networks (BNs) are used in critical care to study organ failure relationships.
  • Limitations exist in using only mortality to assess treatment efficacy.
  • Dynamic BN models offer a more comprehensive approach to understanding organ interactions.

Purpose of the Study:

  • To develop a dynamic Bayesian network (BN) model for detecting interrelationships among failing organs and their progression.
  • To avoid predefining outcomes and hierarchization of organ interactions.
  • To provide a tool for predicting organ failure associations and their evolution over time.

Main Methods:

  • Collected data from 850 critically ill patients.
  • Utilized organ failure scores as nodes in the network, assessed daily.
  • Employed a hill climbing method for network structure learning and maximum likelihood for parameter fitting.
  • Developed a dynamic BN model with 15 nodes, representing 5 variables at three time points (ICU admission, day 2, day 7).

Main Results:

  • Identified organ associations with probabilities over 50% to arise at ICU admittance or in subsequent days.
  • Observed persistence of these organ associations over time.
  • The developed network model accurately predicted organ failure associations and their temporal evolution.

Conclusions:

  • The dynamic BN model effectively predicts organ failure associations and their progression in critically ill patients.
  • This approach offers potential advantages in detecting and comparing treatment effects on organ function.
  • Moving beyond mortality-only outcomes provides a richer understanding of critical care dynamics.